|
Disease |
|
|
|
Detail |
| hsa-let-7a |
|
Unspecified |
Detection of let-7a microRNA by real-time PCR in gastric carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-214 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-92-2 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-107 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-223 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-24-1 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-24-2 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-191 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-93 |
|
Causal |
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-106b |
|
Causal |
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. |
2008 |
|
|
|
|
|
|
| hsa-let-7a |
|
Causal |
Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. |
2008 |
|
|
|
|
|
|
| hsa-miR-15b |
|
Causal |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Causal |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-122a |
|
Causal |
MicroRNA-122a functions as a novel tumor suppressor downstream of adenomatous polyposis coli in gastrointestinal cancers. |
2009 |
|
|
|
|
|
|
| hsa-miR--196a-2 |
|
Unspecified |
Association of MicroRNA-196a-2 Gene Polymorphism with Gastric Cancer Risk in a Chinese Population |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Unspecified |
miR-21 microRNA expression in human gastric carcinomas and its clinical association. |
2008 |
|
|
|
|
|
|
| hsa-miR-106b |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-222 |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-25 |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-93 |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-27a |
|
Causal |
MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. |
2009 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. |
2009 |
|
|
|
|
|
|
| hsa-miR-106a |
|
Unspecified |
Detection of miR-106a in gastric carcinoma and its clinical significance. |
2009 |
|
|
|
|
|
|
| hsa-miR-451 |
|
Causal |
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-141 |
|
Causal |
Down-regulation of miR-141 in gastric cancer and its involvement in cell growth. |
2009 |
|
|
|
|
|
|
| hsa-miR-143 |
|
Causal |
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers. |
2009 |
|
|
|
|
|
|
| hsa-miR-145 |
|
Causal |
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers. |
2009 |
|
|
|
|
|
|
| hsa-miR-512-5p |
|
Unspecified |
Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. |
2009 |
|
|
|
|
|
|